Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Haploidentical or Matched Donor Virus-Specific T-cells (Cytomegalovirus (CMV) or Adenovirus (AdV)) to Treat CMV or AdV Reactivation or Disease in Patients After Solid Organ or Hematopoietic Stem Cell Transplantation (HCT)

NCT03665675 is registered in ClinicalTrials.gov with Sumithira Vasu as lead sponsor.

NCT NCT03665675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03665675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Haploidentical or Matched Donor Virus-Specific T-cells (Cytomegalovirus (CMV) or Adenovirus (AdV)) to Treat CMV or AdV Reactivation or Disease in Patients After Solid Organ or Hematopoietic Stem Cell Transplantation (HCT)
Lead sponsor
Sumithira Vasu
Phase
Phase 1
Overall status
Recruiting
Start date
November 7, 2020
Completion date
June 20, 2027
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adenovirus, allogeneic hematopoietic stem cell transplantation recipient, cytomegalovirus, donor, solid organ transplantation recipient